Deutsche Bank’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-30
Closed -$2K 4286
2019
Q4
$2K Sell
30
-266
-90% -$22.1K ﹤0.01% 4803
2019
Q3
$22K Buy
296
+45
+18% +$3.08K ﹤0.01% 4282
2019
Q2
$18K Hold
251
﹤0.01% 4838
2019
Q1
$20K Buy
251
+176
+235% +$14.4K ﹤0.01% 4788
2018
Q4
$6K Buy
+75
New +$6.59K ﹤0.01% 4944
2018
Q3
Sell
-2,684
Closed -$248K 5330
2018
Q2
$248K Buy
2,684
+2,426
+940% +$237K ﹤0.01% 4193
2018
Q1
$23K Buy
258
+200
+345% +$22K ﹤0.01% 4959
2017
Q4
$5K Sell
58
-633
-92% -$59.7K ﹤0.01% 4855
2017
Q3
$61K Buy
691
+592
+598% +$45.1K ﹤0.01% 4312
2017
Q2
$7K Sell
99
-551
-85% -$37K ﹤0.01% 4705
2017
Q1
$42K Sell
650
-350
-35% -$22K ﹤0.01% 4274
2016
Q4
$62K Buy
1,000
+500
+100% +$30.5K ﹤0.01% 4283
2016
Q3
$31K Sell
500
-1,146
-70% -$74.2K ﹤0.01% 4387
2016
Q2
$100K Sell
1,646
-1,316
-44% -$80.2K ﹤0.01% 4107
2016
Q1
$168K Buy
2,962
+890
+43% +$49.6K ﹤0.01% 3739
2015
Q4
$121K Sell
2,072
-8,358
-80% -$481K ﹤0.01% 3975
2015
Q3
$567K Sell
10,430
-424
-4% -$27.6K ﹤0.01% 3295
2015
Q2
$728K Buy
10,854
+4,935
+83% +$322K ﹤0.01% 3167
2015
Q1
$346K Buy
+5,919
New +$358K ﹤0.01% 3497

Other funds holding ABBV

Deutsche Bank's ABBV Position: Q2 2026 in Review

Deutsche Bank increased its AbbVie (ABBV) stake by 13% in Q2 2026, buying an estimated $267M and bringing the position to 10,772,949 shares worth $2.71B. The position accounts for 0.79% of the portfolio, ranked #18.

Deutsche Bank first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Deutsche Bank held 10,772,949 shares of AbbVie worth $2.71B as of Q2 2026.
  • Deutsche Bank bought 1,241,587 AbbVie shares in Q2 2026, an estimated $267M.
  • AbbVie made up 0.79% of Deutsche Bank's portfolio in Q2 2026, its #18 holding.
  • Deutsche Bank first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.